CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal

Positive
AI Analysis

Summary

Summit is divesting a late-stage antibiotic drug to Biossil in a $105 million transaction. The deal represents a strategic asset sale by Summit to focus on other development priorities.

Importance:6/10
Sentiment:
0.30
divestiturelate-stageantibioticasset sale
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 12:48 PM

Read Original